A Phase Ib/II Clinical Trial of Multiple Doses of STSA-1301 Subcutaneous Injection in Healthy Subjects and Patients With Immune Thrombocytopenia (ITP)

​ Conditions: Primary Immune Thrombocytopenia (ITP)

Interventions: Drug: STSA-1301 subcutaneous injection; Drug: Placebo

Sponsors: Jiangsu BioJeTay Biotechnology Co., Ltd.

Not yet recruiting Conditions: Primary Immune Thrombocytopenia (ITP)
Interventions: Drug: STSA-1301 subcutaneous injection; Drug: Placebo
Sponsors: Jiangsu BioJeTay Biotechnology Co., Ltd.
Not yet recruiting